Characterization of hESC-derived erythroid cells by FACS analysis
| Antibody . | Positive range, % (n = 5) . | Mean ± SE . |
|---|---|---|
| HbF | 40.03-96.60 | 66.79 ± 9.88 |
| CD47 | 95.00-99.21 | 97.51 ± 0.85 |
| GPA | 21.31-41.93 | 30.10 ± 3.79 |
| CD71 | 59.40-83.39 | 76.07 ± 4.33 |
| CD44 | 18.61-44.56 | 30.72 ± 4.55 |
| CD45 | 10.06-40.21 | 22.23 ± 5.45 |
| CD41 | 4.44-20.16 | 8.61 ± 2.98 |
| CD14 | 0 | 0 |
| CD15 | 0.20-0.60 | 0.38 ± 0.08 |
| CD34 | 0-1.62 | 0.34 ± 0.32 |
| CD35 | 5.82-17.46 | 9.79 ± 2.00 |
| CD36 | 1.08-13.30 | 4.99 ± 2.14 |
| CD133 | 0 | 0 |
| CD184 (CXCR-4) | 0 | 0 |
| Duffy | 0 | 0 |
| HLAabc | 0.75-6.25 | 4.15 ± 1.14 |
| Antibody . | Positive range, % (n = 5) . | Mean ± SE . |
|---|---|---|
| HbF | 40.03-96.60 | 66.79 ± 9.88 |
| CD47 | 95.00-99.21 | 97.51 ± 0.85 |
| GPA | 21.31-41.93 | 30.10 ± 3.79 |
| CD71 | 59.40-83.39 | 76.07 ± 4.33 |
| CD44 | 18.61-44.56 | 30.72 ± 4.55 |
| CD45 | 10.06-40.21 | 22.23 ± 5.45 |
| CD41 | 4.44-20.16 | 8.61 ± 2.98 |
| CD14 | 0 | 0 |
| CD15 | 0.20-0.60 | 0.38 ± 0.08 |
| CD34 | 0-1.62 | 0.34 ± 0.32 |
| CD35 | 5.82-17.46 | 9.79 ± 2.00 |
| CD36 | 1.08-13.30 | 4.99 ± 2.14 |
| CD133 | 0 | 0 |
| CD184 (CXCR-4) | 0 | 0 |
| Duffy | 0 | 0 |
| HLAabc | 0.75-6.25 | 4.15 ± 1.14 |